Dr. René Willi

Chief Executive Officer - Effective from June 1st, 2024
Member of the Board of Directors
Member of the Audit Committee

CEO Global Oral Reconstruction Group Henry Schein Inc.,
Member of the Henry Schein Inc. Executive Management Committee

René, a Swiss citizen, has been CEO of the Global Oral Reconstruction Group of Henry Schein and a member of its Executive Management Committee since 2021. Before joining Henry Schein, a US-based global healthcare company, he served as Head of the Surgical business unit at the Swiss oral care company Straumann. He started his career as a consultant with McKinsey & Company. René Willi holds a PhD in Technical Sciences from ETH Zürich. He has served as a member of the Board of Directors of medmix since 2022 and will continue to do so until further notice, if re-elected at the upcoming Annual General Meeting.

Education

René holds a master’s degree in chemical engineering, a PhD in technical sciences and a postgraduate master’s degree in industrial engineering and management from the Swiss Federal Institute of Technology ETH Zurich. He is an alumnus of the Medtronic marketing leader program of the Wharton School, University of Pennsylvania.